NewsNation spoke with Dr. Jason Yaun, a pediatrician and professor at the University of Tennessee Health Science Center. A ...

Dr. Michael Reihart, with Penn State Health, also explained who's most at risk for severe illness and how effective this year's vaccine is.

Inhalon’s inhaled antibody therapy aims to address this need, the release said. Its RSV candidate is part of a more broad effort to develop therapies that deliver therapeutic antibodies directly to ...

Babies under 8 months old are eligible to get an RSV vaccine, and women who are pregnant can also get it to protect kids before they're born. The vaccine is available now through March. If you have ...

Biotech firm Moderna reported a bigger-than-expected quarterly loss on Friday, hit by a charge related to its efforts to ...

Moderna CEO Stéphane Bancel deflected concerns about the new presidential administration's potential impact on life sciences ...

The company is now expecting 2025 revenue to range from $1.5 billion to $2.5 billion, with a midpoint of $2.0 billion, while FactSet is expecting $2.4 billion. Most of that will come in the second ...

RSV season is in full swing, according to doctors at Children’s Hospital Colorado. Denver7 spoke with a local family that is all too familiar with the infection.

Moderna reported a Q4 EPS loss of $2.91, missing estimates, with revenue down 66% YoY to $966 million. The company reaffirmed ...

Learn how analytical methodologies can be used to identify RSV pre- and post-fusion proteins for vaccine development.

Shares of Moderna, along with other vaccine makers, dropped further this year as lawmakers advanced President Donald Trump's ...

Respiratory syncytial virus (RSV) is known to cause considerable respiratory infection-related morbidity and mortality worldwide.1,2 Estimates published in 2022 from the UK highlight the ...